BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

863 related articles for article (PubMed ID: 32422349)

  • 1. Fibrinolysis Shutdown Correlation with Thromboembolic Events in Severe COVID-19 Infection.
    Wright FL; Vogler TO; Moore EE; Moore HB; Wohlauer MV; Urban S; Nydam TL; Moore PK; McIntyre RC
    J Am Coll Surg; 2020 Aug; 231(2):193-203.e1. PubMed ID: 32422349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of coagulation function by rotation thromboelastometry in critically ill patients with severe COVID-19 pneumonia.
    Pavoni V; Gianesello L; Pazzi M; Stera C; Meconi T; Frigieri FC
    J Thromb Thrombolysis; 2020 Aug; 50(2):281-286. PubMed ID: 32394236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High D dimers and low global fibrinolysis coexist in COVID19 patients: what is going on in there?
    Ibañez C; Perdomo J; Calvo A; Ferrando C; Reverter JC; Tassies D; Blasi A
    J Thromb Thrombolysis; 2021 Feb; 51(2):308-312. PubMed ID: 32671609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thromboelastography Profiles of Critically Ill Patients With Coronavirus Disease 2019.
    Yuriditsky E; Horowitz JM; Merchan C; Ahuja T; Brosnahan SB; McVoy L; Berger JS
    Crit Care Med; 2020 Sep; 48(9):1319-1326. PubMed ID: 32618696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thromboelastography clot strength profiles and effect of systemic anticoagulation in COVID-19 acute respiratory distress syndrome: a prospective, observational study.
    Bocci MG; Maviglia R; Consalvo LM; Grieco DL; Montini L; Mercurio G; Nardi G; Pisapia L; Cutuli SL; Biasucci DG; Gori C; Rosenkranz R; De Candia E; Carelli S; Natalini D; Antonelli M; Franceschi F
    Eur Rev Med Pharmacol Sci; 2020 Dec; 24(23):12466-12479. PubMed ID: 33336766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COVID-19-Related Severe Hypercoagulability in Patients Admitted to Intensive Care Unit for Acute Respiratory Failure.
    Spiezia L; Boscolo A; Poletto F; Cerruti L; Tiberio I; Campello E; Navalesi P; Simioni P
    Thromb Haemost; 2020 Jun; 120(6):998-1000. PubMed ID: 32316063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prominent changes in blood coagulation of patients with SARS-CoV-2 infection.
    Han H; Yang L; Liu R; Liu F; Wu KL; Li J; Liu XH; Zhu CL
    Clin Chem Lab Med; 2020 Jun; 58(7):1116-1120. PubMed ID: 32172226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imbalance between procoagulant factors and natural coagulation inhibitors contributes to hypercoagulability in the critically ill COVID-19 patient: clinical implications.
    Voicu S; Delrue M; Chousterman BG; Stépanian A; Bonnin P; Malissin I; Deye N; Neuwirth M; Ketfi C; Mebazaa A; Siguret V; Mégarbane B
    Eur Rev Med Pharmacol Sci; 2020 Sep; 24(17):9161-9168. PubMed ID: 32965009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Routine Venous Thromboembolism Prophylaxis May Be Inadequate in the Hypercoagulable State of Severe Coronavirus Disease 2019.
    Maatman TK; Jalali F; Feizpour C; Douglas A; McGuire SP; Kinnaman G; Hartwell JL; Maatman BT; Kreutz RP; Kapoor R; Rahman O; Zyromski NJ; Meagher AD
    Crit Care Med; 2020 Sep; 48(9):e783-e790. PubMed ID: 32459672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The haemostatic profile in critically ill COVID-19 patients receiving therapeutic anticoagulant therapy: An observational study.
    Tsantes AE; Frantzeskaki F; Tsantes AG; Rapti E; Rizos M; Kokoris SI; Paramythiotou E; Katsadiotis G; Karali V; Flevari A; Chrysanthopoulou E; Maratou E; Kyriakou E; Gialeraki A; Bonovas S; Dimopoulos G; Tsangaris I; Armaganidis A
    Medicine (Baltimore); 2020 Nov; 99(47):e23365. PubMed ID: 33217881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study.
    Helms J; Tacquard C; Severac F; Leonard-Lorant I; Ohana M; Delabranche X; Merdji H; Clere-Jehl R; Schenck M; Fagot Gandet F; Fafi-Kremer S; Castelain V; Schneider F; Grunebaum L; Anglés-Cano E; Sattler L; Mertes PM; Meziani F;
    Intensive Care Med; 2020 Jun; 46(6):1089-1098. PubMed ID: 32367170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends and diagnostic value of D-dimer levels in patients hospitalized with coronavirus disease 2019.
    Creel-Bulos C; Liu M; Auld SC; Gaddh M; Kempton CL; Sharifpour M; Sniecinski RM; Maier CL; Nahab FB; Rangaraju S
    Medicine (Baltimore); 2020 Nov; 99(46):e23186. PubMed ID: 33181697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coagulopathy in COVID-19: Manifestations and management.
    Mucha SR; Dugar S; McCrae K; Joseph D; Bartholomew J; Sacha GL; Militello M
    Cleve Clin J Med; 2020 Jul; 87(8):461-468. PubMed ID: 32409435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COVID-19-related laboratory coagulation findings.
    Devreese KMJ
    Int J Lab Hematol; 2021 Jul; 43 Suppl 1(Suppl 1):36-42. PubMed ID: 34288440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypercoagulability of COVID-19 patients in intensive care unit: A report of thromboelastography findings and other parameters of hemostasis.
    Panigada M; Bottino N; Tagliabue P; Grasselli G; Novembrino C; Chantarangkul V; Pesenti A; Peyvandi F; Tripodi A
    J Thromb Haemost; 2020 Jul; 18(7):1738-1742. PubMed ID: 32302438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of severe illness due to COVID-19 based on an analysis of initial Fibrinogen to Albumin Ratio and Platelet count.
    Bi X; Su Z; Yan H; Du J; Wang J; Chen L; Peng M; Chen S; Shen B; Li J
    Platelets; 2020 Jul; 31(5):674-679. PubMed ID: 32367765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of coagulation status using viscoelastic testing in intensive care patients with coronavirus disease 2019 (COVID-19): An observational point prevalence cohort study.
    Collett LW; Gluck S; Strickland RM; Reddi BJ
    Aust Crit Care; 2021 Mar; 34(2):155-159. PubMed ID: 32773357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of indirect markers of hypercoagulability with thromboelastography in severe coronavirus 2019.
    Hightower S; Ellis H; Collen J; Ellis J; Grasso I; Roswarski J; Cap AP; Chung K; Prescher L; Kavanaugh M; Brown T; Nau M; Clark P
    Thromb Res; 2020 Nov; 195():69-71. PubMed ID: 32659463
    [No Abstract]   [Full Text] [Related]  

  • 19. COVID-19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV-2 infection.
    Al-Samkari H; Karp Leaf RS; Dzik WH; Carlson JCT; Fogerty AE; Waheed A; Goodarzi K; Bendapudi PK; Bornikova L; Gupta S; Leaf DE; Kuter DJ; Rosovsky RP
    Blood; 2020 Jul; 136(4):489-500. PubMed ID: 32492712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. D-dimer and mortality in COVID-19: a self-fulfilling prophecy or a pathophysiological clue?
    Breakey N; Escher R
    Swiss Med Wkly; 2020 May; 150():w20293. PubMed ID: 32459857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.